Last reviewed · How we verify

NCT07040696

Accuracy of Venous Excess Ultrasound Score at Hospital Admission to Predict Acute Kidney Injury

Recruiting now Last updated 2 July 2025
What this trial tests

trial testing Venous excess ultrasound score (VEXUS) in Preeclampsia in 40 participants. Currently enrolling.

Timeline
22 June 2025
Primary endpoint
30 December 2025
31 December 2025

Quick facts

Lead sponsorCairo University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date22 June 2025
Primary completion30 December 2025
Estimated completion31 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 40, female only, with Preeclampsia or Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate diagnostic accuracy of venous excess ultrasound score to predict acute kidney injury

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Preeclampsia

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07040696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing